CSP
DFTX

Cary Street Partners’s Definium Therapeutics DFTX Stock Holding History

Cary Street Partners’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$733K Buy
+15,582
New +$385K 0.02% 570

Other funds holding DFTX

PFA
Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
BRG
Bay Rivers Group Williamsburg, Virginia $293M AUM 48.17% 1-Year Est. Return
SCI
Stableford Capital II Scottsdale, Arizona $289M AUM 20.84% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Cary Street Partners's DFTX Position: Q2 2026 in Review

Cary Street Partners opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 15,582 shares worth $733K. The stake represents 0.02% of the portfolio and ranks #570 among its holdings.

17 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Cary Street Partners held 15,582 shares of Definium Therapeutics worth $733K as of Q2 2026.
  • Definium Therapeutics was a new Cary Street Partners position in Q2 2026.
  • Definium Therapeutics made up 0.02% of Cary Street Partners's portfolio in Q2 2026, its #570 holding.
  • 17 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.